↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

34 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Azithromycin  12件: Azithromycin; Azithromycin 250mg capsule; Azithromycin + metronidazole; Azithromycin (zitromax°); Azithromycin + n-acetylcystein + inhaled corticosteroid; Azithromycin dihydrate; Azithromycine; Azithromycine 250 mg; Azithromycin 250 mg tablets; Azithromycin 500 mg film-coated tablet; Po azithromycin; Study medication, azithromycin;   D02134
 D06390
 D07486 
 -   -   6件:
13,
84,
85,
96,
228,
299
 2   Aztreonam  8件: Aztreonam; Aztreonam lysine for inhalation (azli); Aztreonam for inhalation (ai); Aztreonam for inhalation solution (azli); Aztreonam lysine; Aztreonam lysine for inhalation; Nasal aztreonam; Oral aztreonam;   D00240
 D06558 
 -   -   2件:
228,
299
 3   Basiliximab  1件: Basiliximab;   D03058   1件: IL2RA   4件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, JAK-STAT signaling pathway   7件:
2,
50,
65,
66,
97,
222,
228
 4   Bortezomib  6件: Bortezomib; Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone; Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Combination of a single dose anti-cd20 antibody and bortezomib; Bortezomib (velcade®);   D03150   1件: PSMB5   1件: Proteasome   13件:
11,
26,
28,
46,
49,
51,
61,
63,
66,
228,
256,
288,
331
 5   Budesonide  39件: Budesonide; Budesonide ( zentacort capsules 3mg ); Methylprednisolone or budesonide; Budesonide (6 mg); Budesonide (9 mg); Budesonide 6 mg capsules, hard (bux-pvii prototype); Budesonide 9 mg capsules, hard (bux-pv); Budesonide 9 mg capsules, hard (bux-pvii prototype); Budesonide mmx 6 mg tablet; Budesonide mmx®; Budesonide mmx® 6 mg; Budesonide mmx® 9 mg; Budesonide-mmx; Budesonide-mmx®; Budesonide-mmx® 6 mg; Budesonide-mmx® 9 mg; Budesonide-mmx™; Combination oral budesonide and rectal hydrocortisone; 0.5 mg budesonide effervescent tablet for orodispersible use; 1 mg budesonide effervescent tablet for orodispersible use; 1mg budesonide effervescent tablet for orodispersible use; 2mg budesonide effervescent tablet for orodispersible use; Budesonide 0.5mg orodispersible tablet twice daily; Budesonide 1mg orodispersible tablet twice daily; Budesonide [0.4mg/ml] viscous suspension; Budesonide oral suspension; Budesonide oral suspension [0.2 mg/ml]; Budesonide plus prevacid; Inhaled/swallowed budesonide; Oral budesonide; Oral budesonide suspension (mb-9); Oral budesonide suspension (obs); Oral viscous budesonide; Oral viscous budesonide (ovb); Viscous/swallowed budesonide; Budesonide/formoterol; Formoterol/budesonide; Budesonide-formoterol single inhaler; High dose of budesonide;   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   10件:
66,
85,
93,
94,
95,
96,
97,
98,
228,
299
 6   Chloride ion  0件:   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299
 7   Cholecalciferol  9件: Cholecalciferol; Cholecalciferol, vitamin d3; Calcium and cholecalciferol; Cholecalciferol and c. xanthorrhiza; Cholecalciferol 10,000 iu; Cholecalciferol 400 iu; Cholecalciferol concentrate; 5000 iu of cholecalciferol; Cholecalciferol (vitamin d3);   D00188   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   15件:
6,
13,
19,
20,
34,
46,
49,
53,
60,
65,
96,
97,
228,
298,
299
 8   Ciclosporin  7件: Ciclosporin; Ciclosporina; Ciclosporine; Aerolised liposomal ciclosporin a; Ciclosporin (ciclosporinium); Ciclosporin a; Ciclosporine, ciclosporina;   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   44件:
11,
14,
19,
20,
26,
28,
36,
38,
39,
40,
41,
42,
45,
46,
49,
50,
53,
55,
56,
58,
60,
61,
62,
63,
64,
65,
90,
95,
97,
113,
162,
164,
222,
223,
226,
228,
234,
269,
274,
283,
284,
285,
302,
326
 9   Clarithromycin  6件: Clarithromycin; Lansoprazole, clarithromycin, amoxycillin; Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication); Rifabutin, clarithromycin, and clofazimine; Lansoprazole, amoxicillin, clarithromycin; Biaxin ( clarithromycin);   D00276   -   -   8件:
6,
63,
84,
96,
97,
222,
228,
299
 10   Erythromycin  3件: Erythromycin; Erythromycine; Oral erythromycin;   D00140
 D00851
 D01361
 D02009
 D02184
 D02523
 D02524
 D02525
 D04054 
 -   -   5件:
6,
36,
164,
228,
291
 11   Etanercept  39件: Etanercept; Enbrel (etanercept); Etanercept 50 mg solution for injection; 50 mg etanercept; Anti-tnf therapy (etanercept or adalimumab); Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Commercial formulation etanercept; Etanercept (enbrel); Etanercept (enbreltm); Etanercept + methotrexate; Etanercept , methotrexate; Etanercept / autoinjector a; Etanercept 50mg; Etanercept biosimilar; Etanercept liquid; Etanercept or adalimumab; Etanercept pre-filled syringe sq injection; Etanercept treatment; Etanercept via autoinjector a; Etanercept via autoinjector b; Etanercept, other biologics, disease-modifying antirheumatic drugs (dmards), etc; Infliximab, etanercept; Infliximab, etanercept, adalimumab; Methotrexate - etanercept - prednisolone arm; New formulation etanercept; Phase 1: etanercept; Reumatocept (etanercept); Sb4 (etanercept biosimilar); Sb4 (proposed biosimilar to etanercept); Tnf blockers (infliximab, adalimumab, etanercept); Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); Etanercept, methotrexate, prednisolone; Adalimumab, etanercept, golimumab or infliximab; Etanercept (50mg per week); Etanercept (50mg per week, for 2 weeks); Etanercept (50mg per week, for 4 weeks); Etanercept (full-dose); Etanercept (half-dose); Tapering or discontinuation of etanercept;   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
15,
28,
35,
38,
39,
46,
50,
53,
56,
60,
85,
228,
271,
285,
298
 12   Ethanol  14件: Endocannabinoid palmitoylethanolamide (pea); Palmitoylethanolamide; Treprostinil diethanolamine; Ut-15c (treprostinil diethanolamine); Ut-15c sr (treprostinil diethanolamine); Andrographis paniculata (ethanol extract); Ethanol; Ethanol (96 per cent); Ethanol 96% gel; Ethanol 98% solution; Ethanol bp; Ethanol gel; Ethanolamine; Ethanolamine oleate;   D00068
 D02798
 D04855
 D06542 
 -   -   49件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
58,
61,
63,
64,
65,
66,
81,
84,
85,
86,
88,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
279,
280,
283,
284,
285,
288,
298,
299,
300,
331
 13   Everolimus  6件: Everolimus; Everolimus (rad001); Everolimus (rad001) , afinitor®; Rad001, everolimus; Rad001: everolimus; Afinitor (everolimus);   D02714   1件: MTOR   4件: Breast cancer, ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   9件:
34,
67,
89,
96,
137,
157,
158,
228,
277
 14   Fluticasone  5件: Flovent (fluticasone propionate); Fluticasone; Fluticasone mdi; Fluticasone propionate; Swallowed fluticasone;   D07981   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   4件:
98,
228,
299,
306
 15   Fluticasone propionate  2件: Flovent (fluticasone propionate); Fluticasone propionate;   D01708   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   4件:
98,
228,
299,
306
 16   Formoterol  4件: Budesonide/formoterol; Formoterol; Formoterol/budesonide; Budesonide-formoterol single inhaler;   D01373
 D05277
 D07990 
 1件: ADRB2   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, cAMP signaling pathway   4件:
85,
228,
299,
306
 17   Helium  6件: Helium; Helium-3; Hyperpolarized helium-3 mri; Hyperpolarized helium-3; Hyperpolarized helium-3 mri of the chest; Helium / oxygen mixed gas inhalation therapy;   D04420   -   -   3件:
228,
299,
330
 18   Helium He-3  0件:   -   -   -   2件:
228,
299
 19   Interferon gamma-1b  2件: Interferon gamma-1b; Interferon gamma-1b (actimmune);   D00747   2件: IFNGR1, IFNGR2   4件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Pathways in cancer   7件:
65,
85,
90,
228,
299,
301,
326
 20   Itacitinib  1件: Itacitinib;   D10944   1件: JAK1   2件: JAK-STAT signaling pathway, PI3K-Akt signaling pathway   4件:
46,
60,
97,
228
 21   L-Lysine  2件: L-lysine; L-lysine-n-acetylcysteinate;   D02304   -   -   4件:
13,
97,
228,
299
 22   Lactose  4件: Lactose; Lactose monohydrate; 2'-fucosyllactose; Lactose in water;   D00046
 D03226 
 -   -   6件:
2,
6,
13,
97,
228,
310
 23   Montelukast  8件: Montelukast; Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; 5 mg montelukast; Montelukast/ singulair; Montelukast sodium; Montelukast teva; Singulair (montelukast sodium);   D00529
 D08229 
 1件: CYSLTR1   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   5件:
13,
46,
85,
98,
228
 24   Mycophenolic acid  2件: Mycophenolic acid; Mycophenolic acid mofetil;   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   34件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
228,
234,
283,
284,
285,
300
 25   Nintedanib  5件: Nintedanib; L01xe31 - nintedanib; Pirfenidone and nintedanib; Pirfenidone or nintedanib; Sub-study: nintedanib;   D10481   8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB   3件: MAPK signaling pathway, Pathways in cancer, VEGF signaling pathway   4件:
51,
85,
89,
228
 26   Pirfenidone  6件: Pirfenidone; Pirfenidone and nintedanib; Pirfenidone or nintedanib; Pirfenidoneone; Sub-study: pirfenidone; Pirfenidone 267 mg [esbriet];   D01583   6件: CCL2, IL10, IL1A, IL1B, IL6, TNF   5件: Cellular senescence, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, TGF-beta signaling pathway, TNF signaling pathway   10件:
34,
46,
50,
51,
58,
84,
85,
164,
222,
228
 27   Prednisone  59件: Prednisone; Prednisone - azathioprine; Prednisone alone; Granulocyte-colony stimulating factor (g-csf) and prednisone; Prednisone/prednisolone; Prednisone acetate; Prednisone, cyclophosphamide; Over encapsulated prednisone; Prednisone and ustekinumab treatment; Prednisone capsules; Prednisone tablets usp, 1 mg; Prednisone tablets usp, 2.5 mg; Prednisone tablets usp, 5 mg; Prednisone tablets, usp; Prednisone therapy and pharmacokinetic; Prednisone treatment; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Prednisone (and methylprednisolone); 0 mg prednisone; 5 mg prednisone; Methylprednisone; Prednisone 15 mg; Prednisone 5 mg; Prednisone 7.5 mg; Rayos (delayed-release prednisone); Corticosteroids (prednisone or prednisolone); Cyclophosphamide-prednisone-azathioprine; Oral prednisone 5mg; Prednisone discontinuation; Chinese herb prescription granule plus prednisone; Enalapril valsartan methylprednisone; Hormone (prednisone); Leflunomide 20 mg+prednisone 0.5mg/kg/d; Methylprednisolone (mp) or prednisone (pred); Mycophenolate mofetil plus lower dose of prednisone; Prednisone + inhibace/cozaar; Prednisone and cyclophosphamide; Prednisone arrow 20mg; Prednisone arrow 5 mg; Prednisone in full dose; Prednisone or prednisolone; Prednisone plus cyclophosphamide; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Glucocorticoid (prednisone or prednisolone); Hydroxychloroquine + prednisone; Azathioprine/prednisone; 5-asa, prednisone, azathioprine or remicade; 5-aminosalicylic acid(5-asa) and/or prednisone; Treatment systemic therapy (prednisone); Treatment with systemic therapy (prednisone); Prednisone 0,5 mg/kg orally on alternate days; Prednisone, fk506, mmf; Tacrolimus combined with prednisone; Prednisone acetate tablets; Oral prednisone; Sotatercept with prednisone boost; Prednisone and mycophenolate mofetil; Thalidomide, cyclophosphamide and prednisone;   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   44件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331
 28   Ruxolitinib  1件: Ruxolitinib;   D09959   2件: JAK1, JAK2   3件: Chemokine signaling pathway, JAK-STAT signaling pathway, Pathways in cancer   1件:
228
 29   Salbutamol  5件: Salbutamol; Salbutamol 4mg tablet; R-salbutamol; R-salbutamol sulphate; Nebulized combination ipratropium bromide with salbutamol;   D02147   1件: ADRB2   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, cAMP signaling pathway   13件:
3,
11,
12,
13,
49,
85,
86,
89,
113,
228,
231,
256,
299
 30   Sodium chloride  14件: 0.9% sodium chloride; 0.9% sodium chloride (normal saline); Sodium chloride; Sodium chloride solution; Isotonic sodium chloride solution; 0.9% sodium chloride injection; Physiological serum (sodium chloride); Sodium chloride solvent; Sodium chloride solution 0.9%; 0.9% w/v sodium chloride solution; Sodium chloride (7%); Sodium chloride 0,9%; Sodium chloride 6%; Sodium pyruvate in 0.9% sodium chloride solution;   D02056   -   -   19件:
6,
11,
13,
14,
17,
34,
46,
51,
53,
67,
78,
86,
97,
168,
193,
227,
228,
288,
299
 31   Tacrolimus  13件: Tacrolimus; Tacrolimus capsule; Interferon beta-1b and tacrolimus; Non-mtx dmards (e.g. sulfasalazine, leflunomide, bucillamine, tacrolimus, or mizoribin); Tacrolimus (prograf®); Tacrolimus with methotrexate; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Lcp-tacro (tacrolimus); Rectal tacrolimus; Tacrolimus capsules; Tacrolimus combined with prednisone; Tacrolimus and mmf; Tacrolimus prolonged-release hard capsules;   D00107
 D08556 
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   30件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
86,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299
 32   Vitamin D  31件: 10000iu vitamin d; 19 nor vitamin d; 25oh-vitamin d; 5000iu vitamin d; Cholecalciferol, vitamin d3; Low dose arm receiving neutral oil and 400 iu/g of vitamin d every second day; Verum arm receiving vitamin d oil; Vitamin d; Vitamin d3; Alendronate versus alfacalcidol (1-alpha oh vitamin d); Vitamin d in arm b; Vitamin d 25(oh)d; Vitamin d3 400 iu; Vitamin d3 6000 iu; Vitamin d3 3000 ui daily; Vitamin d3 4000 ui daily; Vitamin d3 800 ui/day then 800 ui/day; Vitamin d3: 3000 or 4000 ui/day then 2,000 ui/day; High-dose vitamin d (2000 iu per day); Standard-dose vitamin d (400iu per day); Vitamin d 100ug; Vitamin d 10ug; 25-hydroxyvitamin d3; Cholecalciferol (vitamin d3); D6-25-hydroxyvitamin d3; Ergocalciferol (vitamin d2); High-dose vitamin d3; Supplementation with vitamin d2/d3; Vitamin d oil; Vitamin d powder; Vitamin d2;   -   -   -   18件:
13,
19,
41,
46,
49,
50,
68,
93,
95,
96,
98,
179,
222,
228,
235,
274,
298,
299
 33   Xenon  8件: Xenon; Xenon contrast agent; Hyperpolarized 129 xenon gas comparing idiopathic pulmonary fibrosis (ipf) treatment; Hyperpolarized 129-xenon gas; Hp 129xenon; Hyperpolarized xenon; Hyperpolarized xenon gas; Xenon-129;   D01901
 D06339 
 -   -   5件:
22,
85,
228,
231,
299
 34   Xenon-133  0件:   -   -   -   5件:
22,
85,
228,
231,
299

先頭へ